Earnings History Data for Impel Pharmaceuticals Inc. (IMPL) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Impel Pharmaceuticals Inc.
Impel NeuroPharma Inc. is a late-stage pharmaceutical company. It is focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs. Impel NeuroPharma Inc. is based in SEATTLE.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-05-2023 | PM | 8:00 AM ET (May 12) |
IMPL | Impel Pharmaceuticals Inc. | 57.70 | -1.27 | 0.00 | -1.17 | Impel NeuroPharma GAAP EPS of -$1.27 misses by $0.49, revenue of $4.37M misses by $0.63M [5/12/2023 8:24 AM] |
1.52 | -0.76 (-33.33%) |
2.05 | -0.23 (-10.09%) |
0.93 - 10.75 | 143,036 | 40,000 | 6,985 | |
| 24-03-2023 | PM | 8:00 AM ET (Mar 24) |
IMPL | Impel Pharmaceuticals Inc. | 54.96 | -0.97 | -1.04 | -1.07 | Impel NeuroPharma Non-GAAP EPS of -$0.97 beats by $0.06, revenue of $5.01M misses by $0.24M [3/24/2023 8:27 AM] |
1.25 | -0.06 (-4.58%) |
1.50 | 0.19 (14.50%) |
0.93 - 10.75 | 180,416 | 40,000 | 24,123 | |
| 14-11-2022 | PM | 8:05 AM ET (Nov 14) |
IMPL | Impel Pharmaceuticals Inc. | 93.29 | -1.31 | -0.87 | -1.24 | Impel NeuroPharma GAAP EPS of -$1.31 misses by $0.32, revenue of $3.1M misses by $2.65M [11/14/2022 8:07 AM] |
3.35 | -0.46 (-12.07%) |
3.90 | 0.09 (2.36%) |
3.34 - 11.49 | 91,759 | 30,000 | 59,062 | |
| 15-08-2022 | PM | 8:00 AM ET (Aug 15) |
IMPL | Impel Pharmaceuticals Inc. | 185.63 | -1.09 | -1.13 | -0.79 | Impel NeuroPharma GAAP EPS of -$1.09 misses by $0.04, revenue of $2.8M misses by $1.04M [8/15/2022 8:13 AM] |
7.92 | -0.78 (-8.97%) |
8.64 | -0.06 (-0.69%) |
5.72 - 34.75 | 138,925 | 30,000 | 13,958 | |
| 16-05-2022 | PM | 8:00 AM ET (May 16) |
IMPL | Impel Pharmaceuticals Inc. | 144.37 | -1.17 | -1.08 | -0.54 | Impel NeuroPharma Non-GAAP EPS of -$1.17 misses by $0.16, revenue of $1.8M in-line [5/16/2022 8:08 AM] |
6.79 | 0.33 (5.05%) |
6.31 | -0.15 (-2.32%) |
5.72 - 34.75 | 70,894 | 70,000 | 1,000 | |
| 24-03-2022 | PM | 8:00 AM ET (Mar 24) |
IMPL | Impel NeuroPharma, Inc. | 183.62 | -1.07 | -0.86 | 0.00 | Impel NeuroPharma Non-GAAP EPS of -$1.07 [3/24/2022 8:04 AM] |
7.50 | -0.52 (-6.48%) |
7.53 | -0.49 (-6.11%) |
5.72 - 34.75 | 166,271 | 127,737 | 13,341 | |
| 15-11-2021 | PM | 8:05 AM ET (Nov 15) |
IMPL | Impel NeuroPharma, Inc. | 229.63 | -1.24 | -0.82 | 0.00 | Impel NeuroPharma EPS misses by $0.48 [11/15/2021 8:07 AM] |
11.02 | -0.49 (-4.27%) |
11.25 | -0.26 (-2.26%) |
6.90 - 34.75 | 456,212 | 210,000 | 13,183 | |
| 16-08-2021 | PM | 8:05 AM ET (Aug 16) |
IMPL | Impel NeuroPharma, Inc. | 498.99 | -0.79 | -0.59 | 0.00 | Impel NeuroPharma EPS misses by $0.19 [8/16/2021 8:12 AM] |
12.60 | -1.65 (-11.58%) |
13.60 | -0.65 (-4.56%) |
6.90 - 28.00 | 150,754 | 100,000 | 953 | |